Showing results (471-480 of 487) with videos related to

Sort By:
Pageof 49
The Journal of Urology|October 9, 2003
5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epitheliumL N Thomas, R C Douglas, J P Vessey, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathwaysA W Norman, I Nemere, L X Zhou, et al.
Bone|May 13, 1999
Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressedM L Siu-Caldera, H Sekimoto, A Weiskopf, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1996
Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status reportA W Norman, J E Bishop, E D Collins, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 20, 2010
Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damageR S Mason, V B Sequeira, K M Dixon, et al.
Steroids|February 17, 2001
Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathwaysM R Uskokovic, A W Norman, P S Manchand, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathwayG Wong, R Gupta, K M Dixon, et al.
Journal of the American College of Cardiology|February 1, 2005
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)Kathy A Hodgkinson, Patrick S Parfrey, Anne S Bassett, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 26, 2005
Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogsK M Dixon, S S Deo, G Wong, et al.
Molecular Endocrinology (Baltimore, Md.)|September 1, 1997
Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responsesA W Norman, W H Okamura, M W Hammond, et al.
Pageof 49